These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 9412880

  • 1. A pump-prime aprotinin dose in cardiac surgery: appraisal of its effects on the hemostatic system.
    Rossi M, Storti S, Martinelli L, Varano C, Marra R, Zamparelli R, Possati G, Schiavello R.
    J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):835-9. PubMed ID: 9412880
    [Abstract] [Full Text] [Related]

  • 2. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.
    Gu YJ, de Haan J, Brenken UP, de Boer WJ, Prop J, Van Oeveren W.
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145
    [Abstract] [Full Text] [Related]

  • 3. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
    Koster A, Huebler S, Merkle F, Hentschel T, Gründel M, Krabatsch T, Tambeur L, Praus M, Habazettl H, Kuebler WM, Kuppe H.
    Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
    [Abstract] [Full Text] [Related]

  • 4. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
    Kawasuji M, Ueyama K, Sakakibara N, Tedoriya T, Matsunaga Y, Misaki T, Watanabe Y.
    Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
    [Abstract] [Full Text] [Related]

  • 5. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage.
    Mössinger H, Dietrich W.
    Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S45-50; discussion S50-1, S74-6. PubMed ID: 9647138
    [Abstract] [Full Text] [Related]

  • 6. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A, Hiippala S, Vahtera E, Rasi V, Salmenperä M.
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [Abstract] [Full Text] [Related]

  • 7. Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?
    Englberger L, Kipfer B, Berdat PA, Nydegger UE, Carrel TP.
    Ann Thorac Surg; 2002 Jun; 73(6):1897-904. PubMed ID: 12078788
    [Abstract] [Full Text] [Related]

  • 8. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
    Dietrich W.
    J Cardiovasc Pharmacol; 1996 Jun; 27 Suppl 1():S50-7. PubMed ID: 8938284
    [Abstract] [Full Text] [Related]

  • 9. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y, Takamoto S, Ando M, Morota T, Yamaki F, Matsukawa R, Kawashima Y.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [Abstract] [Full Text] [Related]

  • 10. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
    Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.
    Ann Card Anaesth; 2010 Nov 04; 13(2):110-5. PubMed ID: 20442540
    [Abstract] [Full Text] [Related]

  • 11. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
    Dietrich W, Dilthey G, Spannagl M, Jochum M, Braun SL, Richter JA.
    Anesthesiology; 1995 Oct 04; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
    [Abstract] [Full Text] [Related]

  • 12. Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?
    Steinbrueckner BE, Steigerwald U, Keller F, Neukam K, Elert O, Babin-Ebell J.
    Heart Vessels; 1995 Oct 04; 10(1):46-53. PubMed ID: 7730247
    [Abstract] [Full Text] [Related]

  • 13. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
    Mastroroberto P, Chello M, Zofrea S, Marchese AR.
    Eur J Cardiothorac Surg; 1995 Oct 04; 9(3):143-5. PubMed ID: 7540397
    [Abstract] [Full Text] [Related]

  • 14. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H, Du Buit C, Soria J, Touchot B, Chollet B, Commin PL, Conseiller C, Echter E, Soria C.
    Thromb Haemost; 1994 Sep 04; 72(3):438-43. PubMed ID: 7531877
    [Abstract] [Full Text] [Related]

  • 15. Influence of high- and low-dose aprotinin on activation of hemostasis in open heart operations.
    Dietrich W, Schöpf K, Spannagl M, Jochum M, Braun SL, Meisner H.
    Ann Thorac Surg; 1998 Jan 04; 65(1):70-7; discussion 77-8. PubMed ID: 9456098
    [Abstract] [Full Text] [Related]

  • 16. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation.
    Okita Y, Takamoto S, Ando M, Morota T, Yamaki F, Kawashima Y.
    Circulation; 1996 Nov 01; 94(9 Suppl):II177-81. PubMed ID: 8901742
    [Abstract] [Full Text] [Related]

  • 17. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A, Mateo J, Oliver A, Litvan H, Murillo J, Souto JC, Fontcuberta J.
    Haematologica; 2000 Dec 01; 85(12):1277-84. PubMed ID: 11114135
    [Abstract] [Full Text] [Related]

  • 18. Is reduced systemic heparinization justified with heparin-bonded bypass circuits in cardiac surgery?--Experience with and without aprotinin.
    Kipfer B, Englberger L, Gygax E, Nydegger U, Carrel T.
    Transfus Apher Sci; 2003 Aug 01; 29(1):17-24. PubMed ID: 12877888
    [Abstract] [Full Text] [Related]

  • 19. [The effect of aprotinin and tranexamic acid on fibrinolysis and thrombin generation during cardiopulmonary bypass].
    Risch A, Dorscheid E, Stein G, Seyfert UT, Grundmann U.
    Anaesthesist; 2000 Apr 01; 49(4):279-85. PubMed ID: 10840537
    [Abstract] [Full Text] [Related]

  • 20. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery.
    Mössinger H, Dietrich W, Braun SL, Jochum M, Meisner H, Richter JA.
    Ann Thorac Surg; 2003 Feb 01; 75(2):430-7. PubMed ID: 12607650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.